Tart Cherry for Sleep & Melatonin

Table of Contents

1. Tart Cherry as a Native Melatonin-Containing Food
2. The Howatson 2012 Montmorency Sleep Trial
3. The Pigeon 2010 Elderly Insomnia Pilot
4. Mechanism: Melatonin, Tryptophan, and Anthocyanin Co-Factors
5. Dosing: Juice, Concentrate, Capsules, Whole Fruit
6. Comparison: Tart Cherry vs Conventional Melatonin Tablets
7. Comparison: Tart Cherry vs Valerian, Magnesium, Glycine, L-Theanine
8. Clinical Applications and Patient Selection
9. Timing, Stacking, and a Practical Protocol
10. Cautions, Side Effects, and Drug Interactions
11. Key Research Papers
12. Connections
13. Featured Videos

Tart Cherry as a Native Melatonin-Containing Food

The discovery that fruit could contain meaningful melatonin came as a surprise to the chronobiology field. For most of the 20th century, melatonin was understood as an exclusively vertebrate-pineal hormone — produced by the pineal gland from serotonin, with darkness-triggered release driving the circadian sleep signal. Plant melatonin was first identified in 1995 by two groups — Dubbels and colleagues (with Reiter as a co-author), in edible plants, and Hattori and colleagues — and in St. John's Wort by Murch, Simmons and Saxena in 1997; it was subsequently catalogued across hundreds of plant species, with concentrations spanning seven orders of magnitude from trace amounts to functionally relevant levels.

Tart cherry sits near the top of the dietary list. Burkhardt et al. measured Montmorency cherry melatonin at approximately 13.5 ng/g fresh weight. Pistachios, certain mushrooms (notably Lentinula and Agaricus species), oats, rice bran, and tomatoes all contain measurable melatonin, but tart cherry juice concentrate — with the fruit reduced roughly 7:1 by evaporation — concentrates it to a level where a tablespoon delivers a meaningful biological dose. By contrast, the sweet cherry (Prunus avium) and most commercial fresh-eating cherries contain considerably less melatonin than the Montmorency tart variety. This is one of the rare cases in nutrition science where the cultivar matters as much as the species — "cherry juice" from supermarket sweet cherries does not produce the same sleep effect as Montmorency tart cherry juice concentrate.

The plant biological role of melatonin in cherries is thought to be antioxidant defense in the developing fruit and seed, where melatonin scavenges reactive oxygen species generated by photosynthesis stress. The fruit happens to retain measurable concentrations into the harvested, dried, or juiced product, which is why tart cherry consumption raises human plasma melatonin in measurable amounts.

Back to Table of Contents

The Howatson 2012 Montmorency Sleep Trial

The pivotal modern trial was published by Glyn Howatson and colleagues at Northumbria University in the European Journal of Nutrition in 2012. The design was a randomized, double-blind, placebo-controlled crossover study in 20 healthy young volunteers (mean age ~26, balanced sex). Each subject consumed either 30 ml of Montmorency tart cherry juice concentrate diluted in water (the equivalent of approximately 100 cherries per serving, twice daily) or a non-cherry placebo of similar taste and appearance, for seven consecutive days, with a one-week washout between arms.

The primary outcomes were measured via wrist actigraphy (objective sleep monitoring) and validated sleep questionnaires:

• Total time in bed increased by approximately 24 minutes per night on tart cherry vs placebo
• Total sleep time increased by approximately 34 minutes per night on tart cherry
• Sleep efficiency (the proportion of time in bed spent actually asleep) improved by approximately 6 percentage points
• Urinary 6-sulfatoxymelatonin (the principal melatonin metabolite, the most reliable biomarker of total melatonin exposure) was significantly elevated during the cherry arm vs placebo

The combination of objective actigraphy improvement, subjective sleep-quality improvement, and confirmed elevation of the melatonin metabolite biomarker established mechanistic plausibility: tart cherry juice does not just feel like it works, it raises measurable melatonin output and produces measurable sleep duration improvement of clinically meaningful magnitude. Thirty-four minutes of additional sleep per night, accumulated over a week, is approximately one full night's worth of restored sleep — non-trivial for shift workers, parents of young children, and anyone with chronic mild sleep restriction.

Back to Table of Contents

The Pigeon 2010 Elderly Insomnia Pilot

Wilfred Pigeon and colleagues at the University of Rochester published an earlier pilot in Journal of Medicinal Food in 2010 specifically in older adults with insomnia. The design was a randomized, double-blind, placebo-controlled crossover in 15 adults aged 65 and older with documented insomnia (sleep latency > 30 minutes and/or wake-after-sleep-onset > 30 minutes on at least three nights per week). Subjects consumed 240 ml (8 oz) of tart cherry juice (not concentrate, the ready-to-drink product) twice daily — once in the morning and once 1-2 hours before bed — for two weeks per arm.

Measured with daily sleep diaries, the results compared with placebo were mixed:

• Insomnia severity (Insomnia Severity Index) fell significantly on cherry vs placebo
• Wake after sleep onset (WASO) decreased by approximately 17 minutes per night on cherry — the most clinically meaningful change, as middle-of-the-night awakenings are the most disruptive feature of geriatric insomnia
• Sleep latency (time to fall asleep), total sleep time and sleep efficiency did not improve compared with placebo
• The authors described the effect sizes as moderate and in some cases negligible — equal to or larger than those reported for valerian and for some melatonin studies, but considerably less than those of hypnotic drugs and cognitive behavioral therapy for insomnia (CBT-I)

The Pigeon trial is a small pilot whose placebo-controlled benefit was on insomnia severity and night-time waking rather than total sleep. It was carried out in the population most likely to be looking for a natural sleep aid — older adults with sleep-maintenance insomnia who want to avoid benzodiazepines, Z-drugs, and the cognitive side effects of conventional pharmacotherapy. Together with Howatson's healthy young adults, it means tart cherry has been tested in both age groups, each in one small trial.

Back to Table of Contents

Mechanism: Melatonin, Tryptophan, and Anthocyanin Co-Factors

The sleep effect of tart cherry is not entirely explained by its native melatonin content alone — the doses delivered, while measurable, are at the low end of the range used in conventional melatonin supplementation. Three additional mechanisms contribute:

1. Native melatonin content — as detailed above, 13.5 ng/g in Montmorency cherries, concentrated 5-7× in tart cherry juice concentrate. A 30 ml serving of concentrate delivers approximately 1.5-3 micrograms of melatonin, in the same range as low-dose physiologic melatonin supplements (0.3-1 mg is considered "low dose" pharmacologically, but the bioavailability of food-matrix melatonin is higher than dry tablets due to fat-soluble polyphenol co-absorption).
2. Tryptophan availability — tart cherries contain tryptophan, the amino acid precursor of both serotonin and melatonin. In a fasted overnight state, exogenous tryptophan plus the carbohydrate matrix of cherry juice triggers an insulin response that lowers competing branched-chain amino acids and improves tryptophan transport across the blood-brain barrier, enhancing endogenous serotonin and downstream melatonin synthesis. This is the same biochemical reason a turkey-and-bread-stuffing Thanksgiving meal produces drowsiness.
3. Anthocyanin polyphenol modulation — cyanidin-3-glucoside and related anthocyanins reduce systemic inflammation (lower C-reactive protein, interleukin-6 (IL-6), tumor necrosis factor-alpha), and elevated systemic inflammation is associated with poor sleep architecture, increased REM fragmentation, and worse sleep quality. By dampening systemic inflammation, tart cherry may indirectly improve sleep continuity beyond the direct melatonin effect.

The synergy is the point. A conventional 3 mg melatonin tablet delivers more melatonin than a tart cherry serving, but lacks the tryptophan, the anthocyanin anti-inflammatory effect, and the food-matrix co-factors. The cherry intervention is broader-spectrum but milder per individual mechanism — the typical pattern of dietary versus pharmacologic interventions.

Back to Table of Contents

Dosing: Juice, Concentrate, Capsules, Whole Fruit

The clinically validated doses span a wide range of product forms. The most cost-effective and best-studied form is Montmorency tart cherry juice concentrate (the kind sold in 16 oz / 473 ml bottles in the refrigerator section, typically as "100% tart cherry juice concentrate, not from concentrate" with no added sugar).

• Howatson 2012 protocol: 30 ml (1 tablespoon) of tart cherry juice concentrate, diluted in water, twice daily — once in the morning and once approximately 30-60 minutes before bed
• Pigeon 2010 protocol: 240 ml (8 oz) of ready-to-drink tart cherry juice, twice daily (morning and 1-2 hours before bed)
• Freeze-dried capsules: 480-720 mg of Montmorency tart cherry powder per day, typically taken as one or two capsules in the evening. This is the most diabetes-friendly form (no fruit sugar).
• Whole fruit: Approximately 100-200 fresh tart cherries per day — impractical for most people due to fruit availability and tart taste; this is the equivalent fruit content represented by the concentrated products above
• Frozen tart cherries: Approximately 1-1.5 cups per day, blended into a smoothie. This preserves the anthocyanin content well and avoids the refined-juice concentration concern; suitable for non-diabetic patients

Sugar content is a serious consideration for diabetic, pre-diabetic, and metabolic-syndrome patients. A 30 ml serving of cherry juice concentrate contains approximately 30 grams of sugar (similar to a small soft drink) — the freeze-dried capsule form carries no fruit sugar.

Back to Table of Contents

Comparison: Tart Cherry vs Conventional Melatonin Tablets

A common question is "Why drink expensive cherry juice when a $5 bottle of melatonin tablets contains 100-300× more melatonin per dose?" The answer involves bioavailability, half-life, side-effect profile, and the multi-mechanism issue addressed above.

• Dose — conventional melatonin tablets range from 0.3 mg (physiologic) through 1 mg, 3 mg, 5 mg, 10 mg, and 20 mg (sold over-the-counter (OTC) in the US, prescription-only in most other countries). The most common over-the-counter dose is 3-5 mg, which is approximately 1,000-3,000× the amount in a tart cherry serving on a molecular basis.
• Bioavailability — oral melatonin from tablets has reported bioavailability ranging from 1 to 37% depending on formulation, age, gut microbiome, and CYP1A2 activity. The food-matrix melatonin in tart cherry, packaged with co-occurring fats and polyphenols, may have higher and more consistent bioavailability per molecule delivered.
• Half-life — oral melatonin has a short half-life (~30-60 minutes), which causes the iconic "wake at 3 AM" phenomenon with the larger doses — the exogenous melatonin signal peaks and falls within 2-3 hours, after which natural cortisol rebound can wake the patient. The slow-release of tart cherry food matrix may avoid this; the Pigeon trial specifically showed reduced WASO, suggesting better sleep continuity
• Side effects — high-dose melatonin tablets (5+ mg) commonly produce next-day grogginess, vivid dreams, headache, and (in long-term use) reduction in endogenous nighttime melatonin output as the body downregulates its own production. Tart cherry has not been associated with these side effects in any published trial.
• Cost and convenience — melatonin tablets are far cheaper per dose. Tart cherry juice concentrate runs $0.50-1.00 per daily dose; melatonin tablets are typically <$0.05.
• Typical uses — conventional melatonin tablets are the form used for true circadian-rhythm shifts (jet lag, shift-work sleep disorder, delayed sleep phase syndrome) where the goal is a transient pharmacologic shift. Tart cherry is used for everyday sleep quality, mild insomnia, and by people who have tried and disliked tablet melatonin or are concerned about downregulation.

For shift workers and rotating-schedule healthcare workers, 0.3-0.5 mg dose-titrated melatonin tablets are the usual first-line intervention; tart cherry is used as an add-on or alternative. For the everyday "I want to sleep slightly better" complaint, tart cherry is a dietary option. See our Sleep Hygiene page for the broader behavioral context.

Back to Table of Contents

Comparison: Tart Cherry vs Valerian, Magnesium, Glycine, L-Theanine

Tart cherry is one of several natural sleep interventions with at least some randomized-controlled trial evidence. Comparing across the field:

• Valerian root (Valeriana officinalis) — evidence is mixed across ~16 randomized controlled trials (RCTs), with the largest meta-analysis (Bent 2006 Am J Med) finding modest improvement in subjective sleep quality without consistent objective actigraphy improvement. Adverse effects include morning grogginess and (rarely) liver enzyme elevation. Cherry vs valerian: comparable subjective effect, cherry has objective actigraphy support (Howatson 2012), cherry has cleaner side-effect profile, valerian is faster-acting per dose.
• Magnesium (especially glycinate) — modest randomized controlled trial (RCT) evidence for sleep quality improvement in older adults, particularly in patients with low baseline magnesium status (Abbasi 2012). Cherry vs magnesium: complementary mechanisms (melatonin vs gamma-aminobutyric acid-receptor potentiation), can be stacked, magnesium more useful when restless-legs symptoms are present.
• Glycine — 3 g of oral glycine before bed has small-trial evidence (Inagawa 2006, Yamadera 2007) for improved sleep quality and reduced daytime fatigue, mediated by a hypothermic effect via N-methyl-D-aspartate-receptor antagonism in the suprachiasmatic nucleus. Cherry vs glycine: complementary mechanisms, can be stacked.
• L-Theanine — 200-400 mg has trial evidence for reduced sleep latency and improved sleep quality in children with attention-deficit/hyperactivity disorder (ADHD) (Lyon 2011) and stressed adults (Williams 2020 meta-analysis), via alpha-wave promotion and modest GABAergic effect. Cherry vs L-theanine: complementary mechanisms, can be stacked.
• Chamomile — modest evidence in elderly insomniacs (Adib-Hajbaghery 2017) and postpartum women. Mild, tolerable, traditional. Often combined with tart cherry as evening tea regimen.
• Diphenhydramine / Doxylamine — the dominant over-the-counter sleep aids in the US, both first-generation H1 antihistamines. Strong evidence for short-term efficacy but substantial anticholinergic side effects (dry mouth, urinary retention, next-day cognitive impairment, increased dementia risk with chronic use per the Gray 2015 JAMA Internal Medicine study). These concerns apply chiefly to long-term nightly use; tart cherry has no anticholinergic action.

A combination some people use, drawn from this comparison: tart cherry juice concentrate (30 ml, 30-60 minutes before bed) + magnesium glycinate (400-800 mg in the evening) + L-theanine (200 mg) covers multiple complementary mechanisms with minimal side-effect overlap. For more on the magnesium-sleep connection, see our Magnesium page.

Back to Table of Contents

Clinical Applications and Patient Selection

The patients most likely to benefit from tart cherry as a sleep intervention are those with one or more of the following features:

• Sleep-maintenance insomnia rather than sleep-onset insomnia — the Pigeon trial specifically showed reduced WASO (middle-of-the-night awakenings); cherry is less convincing for "I can't fall asleep" complaints, which respond better to behavioral interventions, valerian, or low-dose pharmacologic melatonin
• Elderly adults with declining endogenous melatonin output — melatonin synthesis declines with age starting in the fourth decade; cherry provides exogenous melatonin in a food-matrix form that older adults often tolerate better than tablet melatonin
• Patients reluctant to take pharmaceutical sleep aids — the broad population of patients who have been offered Z-drugs (zolpidem, eszopiclone) or benzodiazepines and declined due to dependence, cognitive, or fall-risk concerns
• Athletes managing post-event recovery — high training load disrupts sleep architecture; the combined sleep + recovery + anti-inflammatory effect of tart cherry covers multiple post-event recovery goals with one intervention (see the Inflammation & Athletic Recovery deep-dive)
• Shift workers — cherry juice consumed at the end of a night shift can help anchor the desired sleep phase. Best combined with strict light hygiene (blue-light blockers, blackout shades) and timed bright-light exposure
• Patients with insomnia secondary to chronic pain or arthritis — the dual sleep + anti-inflammatory effect (see Arthritis) is particularly well-suited to this population

The patient unlikely to benefit: someone with severe insomnia secondary to obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder, or a primary psychiatric condition (depression, anxiety, post-traumatic stress disorder, PTSD). These conditions have their own specific treatments; tart cherry has not been tested as a treatment for them.

Back to Table of Contents

Timing, Stacking, and a Practical Protocol

How the Howatson 2012 and Pigeon 2010 protocols, and common practice, use tart cherry:

1. Product form by situation: juice concentrate (most studied, cheapest per effective dose) for non-diabetic adults; freeze-dried capsules for diabetic or metabolic-syndrome patients; whole frozen cherries in a smoothie for those who prefer food forms
2. Twice-daily dosing — the validated protocols use morning + evening rather than evening-only. The morning dose helps build steady-state, the evening dose times the melatonin peak
3. Evening dose timing — 30-60 minutes before lights-out for the concentrate; 1-2 hours before bed for the larger volume of ready-to-drink juice (the earlier timing leaves time to pass the extra fluid before sleep, limiting night-time urination)
4. Trial duration — minimum two weeks for the Pigeon protocol, seven days for the Howatson protocol. People commonly judge the effect at two and four weeks
5. Sleep-hygiene foundation — no supplement compensates for poor sleep hygiene. Tart cherry pairs naturally with consistent sleep schedule, dark bedroom, bedroom temperature 65-68°F, blue-light limitation in the evening, and morning bright-light exposure to anchor the circadian rhythm
6. Stacking — commonly combined with magnesium glycinate, L-theanine, glycine, chamomile tea, and other natural sleep aids. With sedating antihistamines, benzodiazepines, Z-drugs, and prescription melatonin agonists (ramelteon) the sedative effect is additive

A regimen modelled on the Howatson protocol for mild sleep-maintenance insomnia: 30 ml Montmorency tart cherry juice concentrate diluted in 8 oz of water, taken at 7 AM and again 60 minutes before the intended sleep time, sometimes paired with 400 mg magnesium glycinate at bedtime, and judged after two weeks.

Back to Table of Contents

Cautions, Side Effects, and Drug Interactions

• Glycemic load — tart cherry juice and concentrate contain substantial sugar (~30 g per 30 ml of concentrate). Freeze-dried capsule forms carry little or none of this sugar. Continuous glucose monitor users typically see a 30-60 mg/dL excursion from a juice serving.
• Iron absorption — high anthocyanin content can modestly chelate non-heme iron; a 2-hour gap between cherry and an iron supplement is the usual way to limit this
• Anticoagulant interaction — tart cherry may modestly enhance the effect of warfarin, apixaban, and other anticoagulants via flavonoid platelet effects. The concern is a greater bleeding tendency; in warfarin users it would show as a rise in the international normalized ratio (INR) on routine monitoring
• Sedating drug interaction — additive effect with benzodiazepines, Z-drugs (zolpidem, eszopiclone), prescription melatonin agonists (ramelteon, tasimelteon), opioids, and sedating antihistamines. Generally well tolerated; the combined drowsiness is the concern
• Allergic cross-reactivity — rare cherry allergy can cross-react with other Prunus species (peach, plum, almond, apricot). People with birch-pollen oral allergy syndrome can react to cherries
• Pregnancy and lactation — whole tart cherries (food amounts) are considered safe in pregnancy; concentrated juice and supplement forms have not been formally studied in pregnancy. Food amounts are the only form with a record of use in pregnancy
• Children — small case reports of tart cherry juice helping pediatric sleep are anecdotal; no formal pediatric trials exist, so there is no tested dose for children
• Sleep disorder differential diagnosis — loud snoring with daytime sleepiness suggests obstructive sleep apnea, which is diagnosed with an overnight sleep study (polysomnography) and treated with continuous positive airway pressure (CPAP), not diet. Sleep-related leg movements suggest restless legs syndrome (often iron-related, see our Ferritin page). A sleep aid does not treat either condition and can hide its symptoms

Back to Table of Contents

Key Research Papers

1. Howatson G et al. (2012). Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. European Journal of Nutrition, 51(8):909-916. — PubMed PMID: 22038497
2. Pigeon WR et al. (2010). Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study. Journal of Medicinal Food, 13(3):579-583. — PubMed PMID: 20438325
3. Burkhardt S et al. (2001). Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries. Journal of Agricultural & Food Chemistry, 49(10):4898-4902. — PubMed PMID: 11600041
4. Garrido M et al. (2013). A jerte valley cherry product provides beneficial effects on sleep quality. Influence on aging. Journal of Nutrition Health & Aging, 17(6):553-560. — PubMed PMID: 23732552
5. Losso JN et al. (2018). Pilot study of the tart cherry juice for the treatment of insomnia and investigation of mechanisms. American Journal of Therapeutics, 25(2):e194-e201. — PubMed PMID: 28901958
6. Dubbels R, Reiter RJ, Klenke E, et al. (1995). Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. Journal of Pineal Research, 18(1):28-31. — PubMed PMID: 7776176
7. Hattori A, Migitaka H, Iigo M, et al. (1995). Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochemistry and Molecular Biology International, 35(3):627-634. — PubMed PMID: 7773197
8. Murch SJ, Simmons CB, Saxena PK (1997). Melatonin in feverfew and other medicinal plants. Lancet, 350(9091):1598-1599. — PubMed PMID: 9393344
9. Kelley DS et al. (2018). A review of the health benefits of cherries. Nutrients, 10(3):368. — PubMed PMID: 29562604
10. Howatson G, Bell PG, et al. (2010). Influence of tart cherry juice on indices of recovery following marathon running. Scandinavian Journal of Medicine & Science in Sports. — PubMed PMID: 19883392
11. Brzezinski A et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews. — PubMed PMID: 15649737
12. Auld F et al. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews. — PubMed PMID: 28648359

PubMed Topic Searches

1. PubMed: Tart cherry sleep / melatonin
2. PubMed: Montmorency cherry insomnia
3. PubMed: Prunus cerasus sleep
4. PubMed: Melatonin in plants / food content
5. PubMed: Tryptophan dietary sleep

Back to Table of Contents

Connections

• All Herbs
• Tart Cherry Overview
• Tart Cherry Benefits Hub
• Tart Cherry for Inflammation & Athletic Recovery
• Tart Cherry for Antioxidant & Brain Health
• Insomnia
• Sleep Hygiene
• Magnesium (Glycinate for Sleep)
• Tryptophan
• Glycine
• Chamomile
• Valerian Root
• Passionflower
• Ferritin (Restless Legs Workup)
• Joint Pain
• History

Back to Table of Contents

Featured Videos

×